{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:13Z","timestamp":1761630373327,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":6423,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1111\/j.1600-6143.2005.00796.x","type":"journal-article","created":{"date-parts":[[2005,4,5]],"date-time":"2005-04-05T06:30:22Z","timestamp":1112682622000},"page":"1032-1041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["IDEC-131 (Anti-CD154), Sirolimus and Donor-Specific Transfusion Facilitate Operational Tolerance in Non-Human Primates"],"prefix":"10.1016","volume":"5","author":[{"given":"Edwin H.","family":"Preston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran K.","family":"Dhanireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank V.","family":"Leopardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Starost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1111\/j.1600-6143.2005.00796.x_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1111\/j.1600-6143.2005.00796.x_bib2","first-page":"136","article-title":"Incidence and consequences of post-transplantation lymphoproliferative disorders.","volume":"10","author":"Boubenider","year":"1997","journal-title":"J Nephrol"},{"issue":"4","key":"10.1111\/j.1600-6143.2005.00796.x_bib3","first-page":"492","article-title":"Lymphomas in the immunocompromised patient.","volume":"25","author":"DeMario","year":"1998","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1111\/j.1600-6143.2005.00796.x_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1681\/ASN.V131277","article-title":"Gastrointestinal complications of transplant immunosuppression.","volume":"13","author":"Helderman","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"6 Suppl. 6","key":"10.1111\/j.1600-6143.2005.00796.x_bib5","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1053\/ajkd.2001.28924","article-title":"Cardiovascular disease and the renal transplant recipient.","volume":"38","author":"Kendrick","year":"2001","journal-title":"Am J Kidney"},{"issue":"6","key":"10.1111\/j.1600-6143.2005.00796.x_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1399-3046.2001.t01-1-00037.x","article-title":"BK virus infection in renal transplant recipients.","volume":"5","author":"Lin","year":"2001","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1111\/j.1600-6143.2005.00796.x_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1399-3062.1999.10103.x","article-title":"Infection in solid organ transplantation.","volume":"1","author":"Snydman","year":"1999","journal-title":"Transpl Infect Dis"},{"issue":"11 Suppl.","key":"10.1111\/j.1600-6143.2005.00796.x_bib8","first-page":"SS5","article-title":"Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.","volume":"71","author":"Kreis","year":"2001","journal-title":"Transplantation"},{"issue":"5","key":"10.1111\/j.1600-6143.2005.00796.x_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0952-7915(02)00376-X","article-title":"Immunotherapy as a means to induce transplantation tolerance.","volume":"14","author":"Adler","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1111\/j.1600-6143.2005.00796.x_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1600-065X.2003.00088.x","article-title":"T-cell costimulatory pathways in allograft rejection and tolerance.","volume":"196","author":"Rothstein","year":"2003","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1111\/j.1600-6143.2005.00796.x_bib11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.282.11.1076","article-title":"The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?","volume":"282","author":"Harlan","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1111\/j.1600-6143.2005.00796.x_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1681\/ASN.V132559","article-title":"The role of novel T cell costimulatory pathways in autoimmunity and transplantation.","volume":"13","author":"Yamada","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1111\/j.1600-6143.2005.00796.x_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.191.4.651","article-title":"CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis.","volume":"191","author":"Blair","year":"2000","journal-title":"J Exp Med"},{"issue":"1409","key":"10.1111\/j.1600-6143.2005.00796.x_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1098\/rstb.2001.0855","article-title":"The role of CD154 in organ transplant rejection and acceptance.","volume":"356","author":"Kirk","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5","key":"10.1111\/j.1600-6143.2005.00796.x_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0952-7915(97)80043-X","article-title":"The CD40 pathway in allograft rejection, acceptance, and tolerance.","volume":"9","author":"Larsen","year":"1997","journal-title":"Curr Opin Immunol"},{"issue":"1 Suppl","key":"10.1111\/j.1600-6143.2005.00796.x_bib16","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00007890-200201151-00012","article-title":"The CD154-CD40 costimulatory pathway in transplantation.","volume":"73","author":"Yamada","year":"2002","journal-title":"Transplantation"},{"issue":"9","key":"10.1111\/j.1600-6143.2005.00796.x_bib17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00007890-200111150-00001","article-title":"Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.","volume":"72","author":"Elster","year":"2001","journal-title":"Transplantation"},{"issue":"14","key":"10.1111\/j.1600-6143.2005.00796.x_bib18","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.96.14.8132","article-title":"Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.","volume":"96","author":"Kenyon","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1111\/j.1600-6143.2005.00796.x_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/9536","article-title":"Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.","volume":"5","author":"Kirk","year":"1999","journal-title":"Nat Med"},{"issue":"6581","key":"10.1111\/j.1600-6143.2005.00796.x_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature"},{"issue":"11","key":"10.1111\/j.1600-6143.2005.00796.x_bib21","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/00007890-199912150-00026","article-title":"Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody.","volume":"68","author":"Pierson","year":"1999","journal-title":"Transplantation"},{"issue":"16","key":"10.1111\/j.1600-6143.2005.00796.x_bib22","doi-asserted-by":"crossref","first-page":"8789","DOI":"10.1073\/pnas.94.16.8789","article-title":"CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.","volume":"94","author":"Kirk","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1111\/j.1600-6143.2005.00796.x_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00007890-200102150-00028","article-title":"Anti- CD154 monoclonal antibody and thromboembolism.","volume":"71","author":"Buhler","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"10.1111\/j.1600-6143.2005.00796.x_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat Med"},{"issue":"3","key":"10.1111\/j.1600-6143.2005.00796.x_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00007890-200208150-00024","article-title":"Anti-CD154 monoclonal antibody and thromboembolism revisted.","volume":"74","author":"Knosalla","year":"2002","journal-title":"Transplantation"},{"issue":"5","key":"10.1111\/j.1600-6143.2005.00796.x_bib26","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.4049\/jimmunol.170.5.2776","article-title":"Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody I DEC-131 in a nonhuman primate model of skin allotransplantation.","volume":"170","author":"Xu","year":"2003","journal-title":"J Immunol"},{"issue":"5","key":"10.1111\/j.1600-6143.2005.00796.x_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00000658-200211000-00018","article-title":"New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.","volume":"236","author":"Sho","year":"2002","journal-title":"Ann Surg"},{"issue":"10","key":"10.1111\/j.1600-6143.2005.00796.x_bib28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00007890-200211270-00002","article-title":"Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.","volume":"74","author":"Montgomery","year":"2002","journal-title":"Transplantation"},{"issue":"11","key":"10.1111\/j.1600-6143.2005.00796.x_bib29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/15260","article-title":"Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.","volume":"5","author":"Wells","year":"1999","journal-title":"Nat Med"},{"issue":"21","key":"10.1111\/j.1600-6143.2005.00796.x_bib30","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1073\/pnas.92.21.9560","article-title":"Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.","volume":"92","author":"Parker","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1111\/j.1600-6143.2005.00796.x_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/096368979600500109","article-title":"Induction of immunological tolerance to islet allografts.","volume":"5","author":"Rossini","year":"1996","journal-title":"Cell Transplant"},{"issue":"11","key":"10.1111\/j.1600-6143.2005.00796.x_bib32","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1172\/JCI2703","article-title":"Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferongamma, and CTLA4.","volume":"101","author":"Markees","year":"1998","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1111\/j.1600-6143.2005.00796.x_bib33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4049\/jimmunol.164.1.512","article-title":"Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of allore- active CD8+ T cells and prolonged graft survival in a CTLA4- dependent manner.","volume":"164","author":"Iwakoshi","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"10.1111\/j.1600-6143.2005.00796.x_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1034\/j.1600-6143.2002.20415.x","article-title":"Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model.","volume":"2","author":"Montgomery","year":"2002","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1111\/j.1600-6143.2005.00796.x_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"issue":"6","key":"10.1111\/j.1600-6143.2005.00796.x_bib36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/00007890-200203270-00006","article-title":"Blockade of CD40- CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.","volume":"73","author":"Ringers","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"10.1111\/j.1600-6143.2005.00796.x_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI9586","article-title":"The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.","volume":"106","author":"Kishimoto","year":"2000","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1111\/j.1600-6143.2005.00796.x_bib38","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00007890-200210150-00006","article-title":"Anti-CD40 therapy extends renal allograft survival in rhesus macaques.","volume":"74","author":"Pearson","year":"2002","journal-title":"Transplantation"},{"issue":"12","key":"10.1111\/j.1600-6143.2005.00796.x_bib39","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI200317477","article-title":"Heterologous immunity provides a potent barrier to transplantation tolerance.","volume":"111","author":"Adams","year":"2003","journal-title":"J Clin Invest"},{"issue":"9346","key":"10.1111\/j.1600-6143.2005.00796.x_bib40","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(02)11606-0","article-title":"Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy.","volume":"360","author":"Swanson","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1111\/j.1600-6143.2005.00796.x_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.1425","article-title":"CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.","volume":"201","author":"Buchner","year":"2003","journal-title":"J Pathol"},{"issue":"6667","key":"10.1111\/j.1600-6143.2005.00796.x_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1111\/j.1600-6143.2005.00796.x_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1182\/blood.V98.4.1047","article-title":"The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.","volume":"98","author":"Henn","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1111\/j.1600-6143.2005.00796.x_bib44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.TP.0000110291.29370.C0","article-title":"Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates.","volume":"77","author":"Koyama","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1111\/j.1600-6143.2005.00796.x_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007890-199701150-00002","article-title":"FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts.","volume":"63","author":"Knechtle","year":"1997","journal-title":"Transplantation"},{"issue":"1","key":"10.1111\/j.1600-6143.2005.00796.x_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00007890-199707150-00022","article-title":"Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3- immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts.","volume":"64","author":"Thomas","year":"1997","journal-title":"Transplantation"},{"issue":"9","key":"10.1111\/j.1600-6143.2005.00796.x_bib47","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/00007890-199805150-00003","article-title":"Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proin- flammatory cytokine control.","volume":"65","author":"Contreras","year":"1998","journal-title":"Transplantation"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2005.00796.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522036619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522036619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2005.00796.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:34:35Z","timestamp":1761626075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522036619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1600613522036619"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00796.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"type":"print","value":"1600-6135"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IDEC-131 (Anti-CD154), Sirolimus and Donor-Specific Transfusion Facilitate Operational Tolerance in Non-Human Primates","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00796.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}